These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20335422)

  • 1. USA600 (ST45) methicillin-resistant Staphylococcus aureus bloodstream infections in urban Detroit.
    Moore CL; Osaki-Kiyan P; Perri M; Donabedian S; Haque NZ; Chen A; Zervos MJ
    J Clin Microbiol; 2010 Jun; 48(6):2307-10. PubMed ID: 20335422
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit.
    Chua T; Moore CL; Perri MB; Donabedian SM; Masch W; Vager D; Davis SL; Lulek K; Zimnicki B; Zervos MJ
    J Clin Microbiol; 2008 Jul; 46(7):2345-52. PubMed ID: 18508934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in the molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream infections in Taiwan.
    Chen CJ; Hsueh PR; Su LH; Chiu CH; Lin TY; Huang YC
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):199-201. PubMed ID: 19748434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
    Lewis T; Chaudhry R; Nightingale P; Lambert P; Das I
    Int J Infect Dis; 2011 Feb; 15(2):e131-5. PubMed ID: 21134776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant
    Ozmen Capin BB; Tekeli A; Karahan ZC
    Microb Drug Resist; 2020 Mar; 26(3):238-244. PubMed ID: 31545160
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin.
    Welsh KJ; Abbott AN; Lewis EM; Gardiner JM; Kruzel MC; Lewis CT; Mohr JF; Wanger A; Armitige LY
    J Clin Microbiol; 2010 Mar; 48(3):894-9. PubMed ID: 20089758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility profiles of Staphylococcus aureus isolated in 2007 from French patients with bloodstream infections: goodbye hVISA, welcome Geraldine?
    Gallon O; Lamy B; Laurent F; Reverdy ME; Doucet-Populaire F; Decousser JW;
    J Antimicrob Chemother; 2010 Jun; 65(6):1297-9. PubMed ID: 20410064
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
    Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged.
    Barry A; McNicholas S; Smyth E; Humphreys H; Fitzpatrick F
    J Hosp Infect; 2010 Nov; 76(3):272-3. PubMed ID: 20435374
    [No Abstract]   [Full Text] [Related]  

  • 10. Small-Colony Variants in Persistent and Recurrent Staphylococcus aureus Bacteremia.
    Kim NH; Kang YM; Han WD; Park KU; Park KH; Yoo JI; Lee DG; Park C; Song KH; Kim ES; Park SW; Kim NJ; Oh MD; Kim HB
    Microb Drug Resist; 2016 Oct; 22(7):538-544. PubMed ID: 26982169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.
    Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of resistance to mupirocin in methicillin-resistant Staphylococcus aureus isolates in a tertiary hospital in Spain.
    Daskalaki M; Otero JR; Chaves F
    J Antimicrob Chemother; 2009 Apr; 63(4):826-8. PubMed ID: 19223301
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Martín-Gandul C; López-Medrano F; de Gopegui ER; Ramón Blanco J; García-Pardo G; Calbo E; Horcajada JP; Granados A; Jover-Sáenz A; Dueñas C; Pujol M;
    Clin Microbiol Infect; 2014 Apr; 20(4):361-7. PubMed ID: 23991832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and phenotypic characterization of methicillin-resistant Staphylococcus aureus isolates causing bacteremia at a major hospital in southern Mississippi.
    Samanta D; Batte JL; Brown SN; Crosby AG; Marcos LA; Elasri MO
    Am J Infect Control; 2015 May; 43(5):540-2. PubMed ID: 25737304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative epidemiology of bacteremia due to methicillin-resistant Staphylococcus aureus between older and younger adults: a propensity score analysis.
    Kullar R; Rybak MJ; Kaye KS
    Infect Control Hosp Epidemiol; 2013 Apr; 34(4):400-6. PubMed ID: 23466914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methicillin-resistant Staphylococcus aureus (MRSA) in hospitalized children: correlation of molecular analysis with clinical presentation and antibiotic susceptibility testing (ABST) results.
    Abdel-Haq N; Al-Tatari H; Chearskul P; Salimnia H; Asmar BI; Fairfax MR; Amjad M
    Eur J Clin Microbiol Infect Dis; 2009 May; 28(5):547-51. PubMed ID: 19020911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Seah J; Lye DC; Ng TM; Krishnan P; Choudhury S; Teng CB
    Virulence; 2013 Nov; 4(8):734-9. PubMed ID: 24165210
    [No Abstract]   [Full Text] [Related]  

  • 19. Best alternative to vancomycin for serious methicillin-resistant Staphylococcus aureus infections: let's just say it.
    Bush LM
    Clin Infect Dis; 2011 Nov; 53(9):965-6. PubMed ID: 21880584
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.
    Lin SY; Chen TC; Chen FJ; Chen YH; Lin YI; Siu LK; Lu PL
    J Microbiol Immunol Infect; 2012 Dec; 45(6):435-41. PubMed ID: 22749725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.